[HTML][HTML] Ewing sarcoma meets epigenetics, immunology and nanomedicine: moving forward into novel therapeutic strategies

S Sánchez-Molina, E Figuerola-Bou… - Cancers, 2022 - mdpi.com
Simple Summary Ewing Sarcoma treatment is traditionally based on chemotherapy, surgery,
and radiotherapy. Although these standard of care regimens are efficient at early disease …

[HTML][HTML] Antibody conjugates for sarcoma therapy: how far along are we?

L Polito, G Calafato, M Bortolotti, C Chiarelli Olivari… - Biomedicines, 2021 - mdpi.com
Sarcomas are one of the most difficult type of cancer to manage and treat because of their
extremely heterogeneous molecular and morphological features. Despite the progress …

[HTML][HTML] A novel treatment for Ewing's sarcoma: chimeric antigen receptor-T cell therapy

Z Lin, Z Wu, W Luo - Frontiers in Immunology, 2021 - frontiersin.org
Ewing's sarcoma (EWS) is a malignant and aggressive tumor type that predominantly occurs
in children and adolescents. Traditional treatments such as surgery, radiotherapy and …

[HTML][HTML] NPM1 is a novel therapeutic target and prognostic biomarker for ewing sarcoma

Y Zhou, Y Fang, J Zhou, Y Liu, S Wu, B Xu - Frontiers in Genetics, 2021 - frontiersin.org
Ewing sarcoma (ES) is a cancer that may originate from stem mesenchymal or neural crest
cells and is highly prevalent in children and adolescents. In recent years, targeted therapies …

[PDF][PDF] Potential for using EGFR expression in rhabdomyosarcoma, osteosarcoma and ewing's sarcoma: clinicopathological and prognostic significance

HF Huwait, HQ Almaghrabi, MF Gayyed… - Scientific Journal of …, 2022 - researchgate.net
Sarcomas are a heterogeneous group of malignant tumors that arise from mesenchymal
cells and can arise anywhere in the body, whether it is soft tissue or bone. Epidermal growth …

[引用][C] Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers 2022, 14, 5473

S Sánchez-Molina, E Figuerola-Bou… - 2022 - europepmc.org
Ewing Sarcoma (EWS) is an aggressive bone and soft tissue tumor that mainly affects
children, adolescents, and young adults. The standard therapy, including chemotherapy …